TNF Pharmaceuticals Inc. announced an amendment to its bylaws, effective May 9, 2025. The amendment modifies Article II, Section 2.09, changing the required stockholder vote for matters other than the election of directors. The new rule requires a majority of votes cast by stockholders present or represented by proxy, excluding abstentions and broker non-votes, for approval. This change also applies to class votes, where applicable.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.